These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 20350966)
1. Screening of late-onset Pompe disease in a sample of Mexican patients with myopathies of unknown etiology: identification of a novel mutation in the acid alpha-glucosidase gene. Alcántara-Ortigoza MA; González-del Angel A; Barrientos-Ríos R; Cupples C; Garrido-García LM; de León-Bojorge B; Alva-Chaire Adel C J Child Neurol; 2010 Aug; 25(8):1034-7. PubMed ID: 20350966 [TBL] [Abstract][Full Text] [Related]
2. Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype. Kroos MA; Pomponio RJ; Hagemans ML; Keulemans JL; Phipps M; DeRiso M; Palmer RE; Ausems MG; Van der Beek NA; Van Diggelen OP; Halley DJ; Van der Ploeg AT; Reuser AJ Neurology; 2007 Jan; 68(2):110-5. PubMed ID: 17210890 [TBL] [Abstract][Full Text] [Related]
3. First clinical and genetic description of a family diagnosed with late-onset Pompe disease from Costa Rica. Torrealba-Acosta G; Rodríguez-Roblero MC; Bogantes-Ledezma S; Carazo-Céspedes K; Desnuelle C Neuromuscul Disord; 2017 Oct; 27(10):951-955. PubMed ID: 28694071 [TBL] [Abstract][Full Text] [Related]
4. A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations. Herzog A; Hartung R; Reuser AJ; Hermanns P; Runz H; Karabul N; Gökce S; Pohlenz J; Kampmann C; Lampe C; Beck M; Mengel E Orphanet J Rare Dis; 2012 Jun; 7():35. PubMed ID: 22676651 [TBL] [Abstract][Full Text] [Related]
5. Identification of eight novel mutations of the acid alpha-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II. Wan L; Lee CC; Hsu CM; Hwu WL; Yang CC; Tsai CH; Tsai FJ J Neurol; 2008 Jun; 255(6):831-8. PubMed ID: 18458862 [TBL] [Abstract][Full Text] [Related]
6. Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutations. Oba-Shinjo SM; da Silva R; Andrade FG; Palmer RE; Pomponio RJ; Ciociola KM; S Carvalho M; Gutierrez PS; Porta G; Marrone CD; Munoz V; Grzesiuk AK; Llerena JC; Berditchevsky CR; Sobreira C; Horovitz D; Hatem TP; Frota ER; Pecchini R; Kouyoumdjian JA; Werneck L; Amado VM; Camelo JS; Mattaliano RJ; Marie SK J Neurol; 2009 Nov; 256(11):1881-90. PubMed ID: 19588081 [TBL] [Abstract][Full Text] [Related]
7. New mutations and genotype-phenotype correlation in late-onset Pompe patients. Bekircan-Kurt CE; Güneş HN; Yildiz FG; Saka E; Tan E; Erdem-Özdamar S Acta Neurol Belg; 2017 Mar; 117(1):269-275. PubMed ID: 28032299 [TBL] [Abstract][Full Text] [Related]
12. Molecular diagnosis of German patients with late-onset glycogen storage disease type II. Joshi PR; Gläser D; Schmidt S; Vorgerd M; Winterholler M; Eger K; Zierz S; Deschauer M J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S261-5. PubMed ID: 18607768 [TBL] [Abstract][Full Text] [Related]
13. Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: identifying c.2238G > C as the most common mutation. Liu X; Wang Z; Jin W; Lv H; Zhang W; Que C; Huang Y; Yuan Y BMC Med Genet; 2014 Dec; 15():141. PubMed ID: 25526786 [TBL] [Abstract][Full Text] [Related]